Skip to main content
Premium Trial:

Request an Annual Quote

University at Buffalo Acquires IBM Supercomputer

NEW YORK, March 25 (GenomeWeb News) - The University at Buffalo has acquired an IBM supercomputer for predicting the structure and function of proteins, IBM said today.

 

The new cluster, consisting of 266 IBM eServer BladeCenter HS20 systems and 5 terabytes of TotalStorage FAStT700 storage servers, will be used by UB's Center of Excellence in Bioinformatics. It replaces an older cluster of Dell servers and EMC storage systems.

 

IBM researchers will provide algorithms for discovering patterns and correlations and will collaborate with UB scientists. UB is part of the State University of New York.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.